Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Use this CRSP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CRSP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CRSP SEC filings page. Lician reads the product cache first so this HTML stays unique to Crispr Therapeutics AG even when a live quote feed is slow.
Latest cached year on this hub. Full CRSP income, balance, and cash tables.